Output Biosciences
Output Biosciences is pioneering Biologically-Aware Generative AI to understand complex biological systems, aiming to build Large Biological Models that can generate breakthrough medicines. The company is led by experienced founders in AI-driven biotech, physicians, and researchers, positioning itself at the forefront of biology and generative AI to transform disease diagnosis, treatment, and prevention. With a strong focus on advancing health, Output Biosciences is well-positioned in the biotech market, leveraging its unique generative AI architecture to handle complex biological data.
Output Biosciences
Output Biosciences is pioneering Biologically-Aware Generative AI to understand complex biological systems, aiming to build Large Biological Models that can generate breakthrough medicines. The company is led by experienced founders in AI-driven biotech, physicians, and researchers, positioning itself at the forefront of biology and generative AI to transform disease diagnosis, treatment, and prevention. With a strong focus on advancing health, Output Biosciences is well-positioned in the biotech market, leveraging its unique generative AI architecture to handle complex biological data.
TL;DR
Stage: Pre-seed, private
Focus: Biologically-aware generative AI / Large Biological Models for drug discovery
Headquarters: New York, NY
Notable investor: Y Combinator
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Drug discovery and computational biology using generative AI
Founded
2021
Industry
Biotechnology Research
Tech Stack
Funding Track Record
Crunchbase lists one pre-seed round and identifies Y Combinator as a funder; specific amount obfuscated.
Investor Signal
“Y Combinator participation indicates early accelerator backing”